Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

Brain Neoplasms 9Squamous Cell Carcinoma of Head and Neck 7Glioblastoma 7Polycythemia Vera 6Gliosarcoma 6Leukemia 5Head and Neck Neoplasms 5Meningioma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Neoplasms 3Myelodysplastic Syndromes 3Laryngeal Neoplasms 3Central Nervous System Neoplasms 3Thrombocythemia, Essential 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Oropharyngeal Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Hypopharyngeal Neoplasms 2Glioma 2Congenital Abnormalities 2Carcinoma, Squamous Cell 2Astrocytoma 2

Interventions

Cetuximab 11Cisplatin 10Radiotherapy 8Docetaxel 8Erlotinib Hydrochloride 7Paclitaxel 6Gemcitabine 6Chemotherapy, Adjuvant 6Immunohistochemistry 5Sorafenib 4Radiosurgery 4Carboplatin 4Capecitabine 4Biopsy 4sargramostim 3Vorinostat 3Trastuzumab 3Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Nivolumab 3N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 3Lapatinib 3Irinotecan 3Filgrastim 3Doxorubicin 3Bevacizumab 3ixabepilone 2aldesleukin 2Taxes 2SS1(dsFv)PE38 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Salivary Gland Neoplasms × Hydroxyurea × Clear all
NCT01847326 2024-07-31

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

University of Chicago

Phase 1 Completed
48 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00023959 2013-02-07

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡